Nia Tatsis
Executive Vice President and Chief Product Affairs OfficerVertex Pharmaceuticals
ProductView Profile →Head of Development · Biogen
Priya Singhal heads development at Biogen, with earlier leadership in drug safety, benefit-risk management and research and development at Biogen, Zafgen and Vertex.
Last reviewed: Nov 2, 2026
Head of Development
Biogen
Last Reviewed: November 2, 2026
Priya Singhal heads development at Biogen, with earlier leadership in drug safety, benefit-risk management and research and development at Biogen, Zafgen and Vertex.
After medical training in Mumbai and public health study at Harvard, Singhal began her drug-development career at Millennium Pharmaceuticals in 2005. She led benefit-risk management for Velcade and other compounds in development.
From 2008 to 2012, Singhal worked at Vertex Pharmaceuticals, where her positions included vice president of medical affairs and responsibility for global patient safety. She joined Biogen in late 2012 as vice president of clinical trials benefit-risk management.
During her first Biogen tenure, through 2018, she took on global safety and benefit-risk leadership and became interim co-lead and senior vice president of global development. She then served as head of research and development and manufacturing at Zafgen from 2019 to 2020.
Singhal returned to Biogen in 2020 as head of global safety and regulatory sciences, with responsibilities that included research and development in China and Japan. She added interim leadership of research and development in 2021. In January 2023, she became executive vice president and head of development.
Singhal earned an M.D. from the University of Mumbai and an MPH in international health from the Harvard School of Public Health. Her clinical training included internal medicine in Mumbai.